Key facts: Aehr Test Systems Raises FY2027 Outlook; Analysts Cut Price Targets

What happened

Aehr Test Systems raised its fiscal 2027 revenue outlook to $150 million, the top of its prior range, and expects non-GAAP net income of at least 20% of sales, citing AI demand and backlog. Lake Street and Jefferies kept Buy ratings but lowered their price targets.

Confirmed

Global impact / market context

Higher expected revenue and income point to stronger demand and potential earnings growth, while the cited backlog suggests orders are already accumulated. Lower price targets despite unchanged Buy ratings show that analysts can become less optimistic about a stock’s valuation even as company guidance improves.

Analyst inference

The article presents two opposing signals for Aehr: management raised its fiscal 2027 outlook, while Lake Street and Jefferies reduced their price targets. The outlook could support expectations for sales, but the target cuts indicate analysts see less potential value than before.

Analyst inference

What to watch

1. Whether Aehr reports fiscal 2027 revenue near $150 million and non-GAAP net income at least 20% of sales, as stated in its raised outlook. Analyst inference
2. Whether the company’s cited AI demand and backlog continue to support sales; weaker orders or delayed deliveries could make the raised revenue outlook harder to achieve. Analyst inference
3. Whether Lake Street or Jefferies change their Buy ratings or price targets again, as further revisions could signal a shift in their expectations for Aehr. Analyst inference

Evidence

• Original source link unavailable